Strategic Impact In
Life Science Markets

strategic impact in life science markets

Tender analytics: meta analysis on win/loss studies in medical capital equipment

Introduction

Medical Devices (and in particular Medical Capital Equipment) are important tender businesses. Winning or losing a tender can dramatically affect your year end results. However, organizations struggle to capture and combine all the relevant information to drive tender strategy. This leads to sub-optimal strategy and implementation (i.e. only focus on pricing) and repeated tender loss. Competitive intelligence methodologies can be used to understand your historic win/loss, and use these insights to drive tender strategy and grow the win ratio. Over many years, suAzio has conducted numerous win/loss studies using tender post decision interview (PDI) techniques, to gather qualitative and quantitative insights.

Methodology

In order to give insight into overall important tender trends in Medical Capital Equipment, we have analyzed 11 win/loss projects including 205 tender PDI’s in medical capital equipment, ranging from MRI to Ultrasound (Figure 1) in various countries and hospital types. In our sample we included 28% tenders won, 72% tenders lost. In this meta analysis we grouped 15 numerical and coded questions across projects.

Results

Understand the purchase journey

If you want to stay ahead of the competition, it is essential to understand what triggers a purchase of new medical equipment. This helps you align better with customers during their purchase journey. Our interviews indicate the top three triggers are: Improved Product Quality (current is obsolete), Need for New or Enhanced Product Features (new equipment can do more/better) and Increase in Procedure volumes (need for additional equipment) (Figure 2).

50/50 split in influence power

The target audience and influence levels within the tender decision is changing all the time. The physician is always present in the tender decision, however in 70% of cases technician and hospital administration are also sitting at the table. The influence level on final decision is therefore shifted towards a 50/50 split between clinical and non-clinical profiles (Figure 3).

Price is not always the key factor in winning

Yes, price is important. That is the main reason for setting up a tender. However, our grouped analysis shows that respondents mention price as a top reason for winning the tender in less than half of all bids.

Product features are primary factors in 78% of won bids. This can range from product performance and quality, to ergonomics.

In addition, customer service and experience with the winning brand are also important factors as well (Figure 4), which indicates that all company departments can contribute to tender win ratio.

Conclusions

Our sample tender analysis shows interesting key numbers in the tender process, supporting decision making in the medical capital equipment tender business. Based on detailed analysis of win/loss data, companies can better structure their customer buying journey, promotional efforts and key organizational changes.

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

More To Explore

Uncategorized

The impact of COVID-19 on the diagnostics field: Laboratory Test Volumes, Challenges and Potential Services to Improve Workflow

Introduction Laboratory testing has a central position in providing insight and direction on the evolution of the COVID-19 pandemic. Laboratories are requested to increase testing volumes and cope with changes in demand and workflows. This may lead to changes in laboratory needs and engagement models.  Therefore, SUAZIO Consulting took a closer look and interviewed a

Uncategorized

Impact of COVID-19 on Surgical Procedure Volumes: An Outlook for 2020

Introduction Major medical device manufacturers indicated their procedure volumes decreased by -80% during Q1 of 2020. In their Q1 earnings reports, they highlighted the cancellation or rescheduling of mainly elective procedures. These manufacturers commented on the potential short-term uptake of procedures and a restoration to normal volumes in Q3/Q4. However, all forecasts were uncertain, and

Work with us?

drop us a line and keep in touch